Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
Cyclacel Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: May 12, 2020
Cyclacel Pharmaceuticals reported fiscal year 2019 executive compensation information on May 12, 2020.
In 2019, three executives at Cyclacel Pharmaceuticals received on average a compensation package of $743K, a 33% increase compared to previous year.
Average pay of disclosed executives at Cyclacel Pharmaceuticals
Spiro Rombotis, Chief Executive Officer, received $1M in total, which increased by 35% compared to 2018. 52% of Rombotis' compensation, or $531K, was in salary. Rombotis also received $159K in bonus, $286K in option awards, as well as $39K in other compensation.
Judy Chiao, Vice President, Clinical Development and Regulatory Affairs, received a compensation package of $671K, which increased by 27% compared to previous year. 55% of the compensation package, or $371K, was in salary.
Paul McBarron, Chief Financial Officer, earned $542K in 2019, a 40% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on May 12, 2020.